Key facts SKU: ALP-IGF Form: Lyophilised powder Presentation: Mass per vial as selected on the product page Appearance (typical): White to off-white lyophilised powder Intended laboratory context Controlled in-vitro models where IGF-axis biology is studied under institutional protocols Analytical characterisation and method development Non-clinical peptide handling and preparation workflows in laboratory settings Specifications Batch identity and purity parameters appear on the COA where stated for the lot supplied Handle as potent laboratory peptide per SDS Documentation scope may be limited to in-house or supplier release records for some lots (see notice in short description) Documentation and batch release COA and SDS are supplied with released lots within the scope described on this page
Chiu M, Sabino C, Taurino G, Bianchi MG, Andreoli R, Giuliani N, Bussolati O (2017) GPNA inhibits the sodium-independent transport system L for neutral amino acids
Kh nng r rng chnh l Ginkgo biloba (bch qu) c gip ch trong vic tng lu thng mu n nhiu b phn khc nhau ca c th
Crossref Sitaraman R, Israel DA, Romero-Gallo J, Peek Jr RM
Reductive addition of glutathione to p-benzoquinone, 2-hydroxy-p-benzoquinone, and p-benzoquinone epoxides
Self-sourcing unregulated product
